San Francisco, United States
Viz.ai, established in 2016, stands at the forefront of the intersection between AI and health care innovation. Their platform, touted as an AI-powered disease detection and care coordination platform, has made significant inroads, establishing deployments across 2,000 hospitals in the United States. This integration allows for the seamless combination of real-time clinical data with deep clinician engagement, ensuring diseases are detected earlier and care teams are effectively coordinated for improved patient outcomes.
The company's breakthrough has resonated within the healthcare sector, earning it the prestigious title of the #1 Healthcare AI Platform according to the Black Book Research survey. Regulatory acknowledgment includes being the first to secure CMS reimbursement for AI, emphasizing its impactful solution.
In a recent development, Hakluyt Capital led a substantial late-stage venture capital investment dated 01 December 2023, signifying robust investor confidence and poised growth potential.
Anumana
